Mahdi Farhan

Extended Valganciclovir Prophylaxis in D+/R− Kidney Transplant Recipients is Associated With Long-Term Reduction in Cytomegalovirus Disease: Two-Year Results of the IMPACT Study

Atul Humar, Ajit P. Limaye, Emily A. Blumberg et al. · Transplantation · 2010 · 208 citations

Medicine, Immunology, Infectious Diseases +15

The PAIN Study: Paracetamol, Aspirin and Ibuprofen New Tolerability Study

Nicholas Moore, Jean-Marie Leparc, Richard A. Wall et al. · Clinical Drug Investigation · 1999 · 147 citations

Nursing, Pharmacology, Pharmacotherapy +13

Incidence of cytomegalovirus UL97 and UL54 amino acid substitutions detected after 100 or 200 days of valganciclovir prophylaxis

Guy Boivin, Nathalie Goyette, Mahdi Farhan et al. · Journal of Clinical Virology · 2012 · 54 citations

Life Sciences, Infectious Diseases, Microbiology +10

Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of NI-0401 (a fully human anti-CD3 monoclonal antibody) in patients with moderate to severe active Crohnʼs disease†

Pieter Stokkers, Ad A. van Bodegraven, Gert Van Assche et al. · Inflammatory Bowel Diseases · 2010 · 45 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Recombinant Phenotyping of Cytomegalovirus Sequence Variants Detected After 200 or 100 Days of Valganciclovir Prophylaxis

Sunwen Chou, Gail I. Marousek, Guy Boivin et al. · Transplantation · 2010 · 26 citations

Life Sciences, Infectious Diseases, Molecular Genetics +17